No effect from double‐blind trial of physostigmine and lecithin in Alzheimer disease

DOI Web Site Web Site 被引用文献3件

抄録

<jats:title>Abstract</jats:title><jats:p>Eight patients with clinically diagnosed mild to severe Alzheimer disease were treated during two six‐week periods by a double‐blind, single‐crossover protocol with placebo or a combination of 18 gm of lecithin and 3 to 10 mg of oral physostigmine daily. No improvement in behavior, recent memory, or other neuro psychological functions occurred.</jats:p>

収録刊行物

被引用文献 (3)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ